Hepatitis B is caused by the hepatitis B virus (HBV), and is transmitted from person to person through contact with bodily fluids, such as:
Hepatitis B exists world-wide, however there are areas where it is a greater risk. The risk is considered greater in areas of Asia, Africa, South America, and the Caribbean. Those individuals with extended stays in those areas may be at increased risk of exposure.
The average incubation period for Hepatitis B Virus is 90 days, and 30-50% of exposed individuals will develop clinical illness.
Early symptoms may include: not feeling well, fatigue, and lack of appetite for one- two weeks.
Other clinical symptoms include:
Hepatitis B can turn into a chronic illness, and may result in chronic liver disease; including liver cirrhosis and liver cancer. (Because of this, Hepatitis B vaccine is considered one vaccine that can prevent cancer – liver cancer)
While there are some treatments available for acute Hepatitis B – the best course of action is preventative care and completion of the Hepatitis B vaccination series.
This series consists of three doses, and should be considered by:
This vaccine series should ideally be begun six months before travel so that the series can be completed before departure. However, if there is not time to complete the standard series, you may have options for the initial doses or an accelerated schedule to have some immunity.
